What's new
By:
Filters
Cystic Fibrosis Forum (EXP)

This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!

Open label for VX 770

D

dasjsmum

New member
Hi Jeana..as far as I know the ph3 still has a while to run?

We're (my son) only about 16wks into the 48week trial? Are you expecting the open label to begin before the ph3 is finished?
 
D

dasjsmum

New member
Hi Jeana..as far as I know the ph3 still has a while to run?

We're (my son) only about 16wks into the 48week trial? Are you expecting the open label to begin before the ph3 is finished?
 
D

dasjsmum

New member
Hi Jeana..as far as I know the ph3 still has a while to run?

We're (my son) only about 16wks into the 48week trial? Are you expecting the open label to begin before the ph3 is finished?
 
D

dasjsmum

New member
Hi Jeana..as far as I know the ph3 still has a while to run?

We're (my son) only about 16wks into the 48week trial? Are you expecting the open label to begin before the ph3 is finished?
 
D

dasjsmum

New member
Hi Jeana..as far as I know the ph3 still has a while to run?
<br />
<br />We're (my son) only about 16wks into the 48week trial? Are you expecting the open label to begin before the ph3 is finished?
 
H

hmw

New member
Is she referring to this? Here, this phase II is no longer recruiting but "Subjects who complete Part A and meet certain response criteria will be invited to enroll in Part B. Part B is an open-label extension and eligible subjects will receive VX-770 twice daily for up to 96 weeks."

<a target=_blank class=ftalternatingbarlinklarge href="http://www.clinicaltrials.gov/ct2/show/study/NCT00953706">clinicaltrials.gov- VX-770 phase II</a>
 
H

hmw

New member
Is she referring to this? Here, this phase II is no longer recruiting but "Subjects who complete Part A and meet certain response criteria will be invited to enroll in Part B. Part B is an open-label extension and eligible subjects will receive VX-770 twice daily for up to 96 weeks."

<a target=_blank class=ftalternatingbarlinklarge href="http://www.clinicaltrials.gov/ct2/show/study/NCT00953706">clinicaltrials.gov- VX-770 phase II</a>
 
H

hmw

New member
Is she referring to this? Here, this phase II is no longer recruiting but "Subjects who complete Part A and meet certain response criteria will be invited to enroll in Part B. Part B is an open-label extension and eligible subjects will receive VX-770 twice daily for up to 96 weeks."

<a target=_blank class=ftalternatingbarlinklarge href="http://www.clinicaltrials.gov/ct2/show/study/NCT00953706">clinicaltrials.gov- VX-770 phase II</a>
 
H

hmw

New member
Is she referring to this? Here, this phase II is no longer recruiting but "Subjects who complete Part A and meet certain response criteria will be invited to enroll in Part B. Part B is an open-label extension and eligible subjects will receive VX-770 twice daily for up to 96 weeks."

<a target=_blank class=ftalternatingbarlinklarge href="http://www.clinicaltrials.gov/ct2/show/study/NCT00953706">clinicaltrials.gov- VX-770 phase II</a>
 
H

hmw

New member
Is she referring to this? Here, this phase II is no longer recruiting but "Subjects who complete Part A and meet certain response criteria will be invited to enroll in Part B. Part B is an open-label extension and eligible subjects will receive VX-770 twice daily for up to 96 weeks."
<br />
<br /><a target=_blank class=ftalternatingbarlinklarge href="http://www.clinicaltrials.gov/ct2/show/study/NCT00953706">clinicaltrials.gov- VX-770 phase II</a>
 
You must log in or register to reply here.
Top